They showed that NP CXCL10 had a good overall performance and their outcomes show how biomarker-based screening can be used to leverage the existing PCR testing potential to rapidly permit the large scale testing for COVID-19 [64]. This evidence concerns the gene CXCL10 and COVID-19.